Merck: Merck KGaA investing $76 million to expand MilliporeSigma manufacturing plant in St. Louis

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced a $76 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri. This investment will triple existing capacity and enhance the company's contract development and manufacturing organization (CDMO) offering, reinforcing its [...] The post Merck KGaA investing $76 million to expand MilliporeSigma manufacturing plant in St. Louis appeared first on Chemical Engineering.